Correction to: Monocyte anisocytosis increases during multisystem inflammatory syndrome in children with cardiovascular complications
verfasst von:
Lael M. Yonker, Oluwakemi Badaki-Makun, Puneeta Arya, Brittany P. Boribong, Gabriela Moraru, Brittany Fenner, Jaimar Rincon, Alex Hopke, Brent Rogers, Jeremiah Hinson, Alessio Fasano, Lilly Lee, Sarah M. Kehoe, Shawn D. Larson, Hector Chavez, Scott Levin, Lyle L. Moldawer, Daniel Irimia
Following the publication of the original article [1], the authors identified that some symbols were absent in the on-line version of Figs. 4 and 5. These Figures have been corrected.
Fig. 4
MDW depends on MIS-C severity and changes through the course of MIS-C diagnosis, treatment, and recovery. A Higher MDW values in MIS-C patients who manifested cardiac complications (Cardiac MIS-C) compared to children with MIS-C without cardiac involvement or presenting with symptoms concerning MIS-C (fever plus recent/current positive SARS-CoV2 PCR or SARS-CoV2 antibodies positive). B ROC in the validation cohort to assess the utility of MDW as a screening tool for cardiac involvement of MIS-C. AUC = area under the curve (fraction). C Blood from children with MIS-C was collected at multiple time points. MDW was plotted by time of collection: at admission, during hospital course, and at discharge or follow-up. Analysis by one way ANOVA. **P < 0.01, ****P < 0.0001. D MDW values from individual patients with MIS-C are plotted over the course of their illness. Black lines connect individual patients with MIS-C. Not all patients provided blood samples at each time point
Fig. 5
Assessment of other hematological parameters in MIS-C. Hematologic parameters, including A white blood cell (WBC), B neutrophil (PMN), C lymphocyte, D monocyte, and E platelet counts were compared between healthy controls, children with non-infectious illness, children with an infectious/inflammatory illness, and children with MIS-C in the validation cohort. Analysis by ordinary one-way ANOVA. ns = non-significant, * P < 0.05, ** P < 0.01, *** P < 0.001. F Receiver operator curve of each hematologic parameter in MIS-C compared to values obtained from children presenting for medical care for infection/inflammatory or non-infectious illness
×
×
The original article has been corrected.
Anzeige
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Correction to: Monocyte anisocytosis increases during multisystem inflammatory syndrome in children with cardiovascular complications
verfasst von
Lael M. Yonker Oluwakemi Badaki-Makun Puneeta Arya Brittany P. Boribong Gabriela Moraru Brittany Fenner Jaimar Rincon Alex Hopke Brent Rogers Jeremiah Hinson Alessio Fasano Lilly Lee Sarah M. Kehoe Shawn D. Larson Hector Chavez Scott Levin Lyle L. Moldawer Daniel Irimia
Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.
Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.
Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.
„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.
Update Innere Medizin
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.
